Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

CRNT vs FRSX: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CRNT Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 7–3 Matrix Metrics)

CRNT Overall Winner 6-Pillar Tally: CRNT 6 – 0 FRSX Matrix Metrics: CRNT 7 – 3 FRSX

As of Nov 16, 2026, Ceragon Networks Ltd (CRNT) is the stronger overall head-to-head candidate over Foresight Autonomous Holdings Ltd. (FRSX) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CRNT carries a Unified Composite Score of 26.6/100 (SELL) at $2.36 (13.7x Forward P/E, 3.5% operating margin), whereas FRSX carries 47.2/100 (HOLD) at $0.55 (N/M Forward P/E, -2642.2% operating margin).

  • Composite vs. Pillar Nuance: While FRSX currently prints a higher short-term Unified Composite Score (47.2/100 HOLD vs. CRNT 26.6/100 SELL), CRNT captures the overall institutional head-to-head verdict (7–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (3.5% vs. -2642.2% operating margin) and revenue trajectory (+11.7% vs. -32.8% YoY).
  • Technical & Structure Timing Caution: CRNT is currently in a Breakdown options structure phase (RSI 56.2); meanwhile FRSX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 20.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CRNT vs FRSX
CRNT NASDAQ Head-to-Head Winner
Ceragon Networks Ltd
Radio & Tv Broadcasting & Communications Equipment
$2.36
-1.26% 1D
Market Cap $217.2M
TTM Revenue $357M
Forward P/E 13.7x
Beta / 30D Vol 1.84β · 77% Vol
Unified Composite Score
26.6 / 100 SELL
Tech 50.0 Fund 35.0 Flow 58.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (1.5% over 20 days), RSI 56
RSI-14: 56.2 · SMA20: $2.19 · SMA50: $2.12
FRSX NASDAQ
Foresight Autonomous Holdings Ltd. American Depositary Shares
Services-Prepackaged Software
$0.55
+0.0% 1D
Market Cap $2.3M
TTM Revenue $445,000
Forward P/E N/M
Beta / 30D Vol 1.10β · 53% Vol
Unified Composite Score
47.2 / 100 HOLD
Tech 50.0 Fund 54.0 Flow 50.0 Mom 63.9
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -19.3%), weak momentum, RSI 21
RSI-14: 20.8 · SMA20: $0.67 · SMA50: $0.89

6-Pillar Scorecard Institutional Category Breakdown (CRNT 6 – 0 FRSX)

Columns: Metric · CRNT · FRSX
1. Valuation Multiples CRNT
Forward P/E 13.7x N/M
Trailing P/E 15.7x N/M
PEG Ratio 8.80x N/M
EV / Revenue 0.6x 5.2x
2. Growth & Scale CRNT
Revenue Growth (YoY) +11.7% -32.8%
Earnings Growth (YoY) N/A +0.0%
TTM Revenue (USD) $357M $445,000
Market Cap $217.2M $2.3M
3. Profitability & Quality CRNT
Gross Margin 34.1% 65.4%
Operating Margin 3.5% -2642.2%
Net Profit Margin -0.3% 0.0%
Return on Equity (ROE) -0.5% -205.9%
4. Balance Sheet & Cash Flow CRNT
Cash Generation (TTM) $13M -$12M EBITDA
Cash Flow Margin 3.6% N/A
Net Cash / Leverage $6.0M Net Cash $1.71 Book/Sh · -205.9% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning CRNT
Options Structure Phase BREAKDOWN UNCLASSIFIED
Current IV / %ile 43.7% (7th %ile) N/A (N/A)
Put/Call OI Skew N/A Thin ADR Chain
OBV Trend / Tech Phase ACCUMULATION · Markup NEUTRAL · Markdown
6. R&D & Supply-Chain Moat CRNT
OpEx & R&D Intensity 30.6% of Rev ($109M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Communication Equipment Operator Auto Parts Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CRNT (7) vs FRSX (3)
Institutional Metric CRNT FRSX Criterion Row Edge
Market Capitalization
Scale
$217.2M $2.3M Larger Scale CRNT
Trailing P/E Ratio
Valuation
15.7x N/M Lower Multiple CRNT
Forward P/E Ratio
Valuation
13.7x N/M Lower Multiple CRNT
Revenue Growth (YoY)
Growth
+11.7% -32.8% Higher Growth CRNT
Operating Margin (TTM)
Profitability
3.5% -2642.2% Higher Margin CRNT
Net Profit Margin
Profitability
-0.3% 0.0% Higher Margin FRSX
Return on Equity (ROE)
Capital Efficiency
-0.5% -205.9% Higher ROE CRNT
52-Week Range Position
Momentum
35% ($2–$3) 2% ($0–$3) Stronger Trend CRNT
Beta / 30D Volatility
Risk Regime
1.84β · 77% Vol 1.10β · 53% Vol Lower Realized Risk FRSX
Unified Institutional Score
Composite Signal
26.6 / 100 (SELL) 47.2 / 100 (HOLD) Higher Composite FRSX
Trailing 12M Revenue (USD)
Operating Scale
$357M $445,000 FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
34.1% 65.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
8.80x PEG · 0.6x EV/Rev N/M PEG · 5.2x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$13M ($6.0M Net Cash) -$12M EBITDA ($1.71 Book/Sh · -205.9% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CRNT +49.45 pp
CRNT: +15.69% · FRSX: -33.76%
3M Horizon CRNT +66.02 pp
CRNT: +11.85% · FRSX: -54.17%
6M Horizon CRNT +67.95 pp
CRNT: -5.98% · FRSX: -73.93%
1Y Horizon CRNT +86.21 pp
CRNT: +11.32% · FRSX: -74.89%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CRNT vs FRSX. Trailing 12-month operating profitability (CRNT 3.5% vs FRSX -2642.2%) and valuation multiples (CRNT 13.7x vs FRSX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

CRNT ADR TTM Benchmark FX-Normalized USD
TTM Revenue$357M
Gross Margin34.1%
Op. Margin3.5%
ROE / Fwd P/E-0.5% · 13.7x
FRSX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$445,000
Gross Margin65.4%
Op. Margin-2642.2%
ROE / Fwd P/E-205.9% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CRNT BREAKDOWN
114d in phase · OBV ACCUMULATION
Current IV 43.7%
IV Percentile 7th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact CRNT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
FRSX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew Thin ADR Chain
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact FRSX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CRNT Moat Profile Cyclical / Execution-Driven Positioning
Communication Equipment Operator
Competes within the Communication Equipment value chain with $217.2M market capitalization and 3.5% operating margin.
OpEx & R&D Reinvestment 30.6% of Rev ($109M)
90D Engineering Disclosures 0 Published
FRSX Moat Profile Cyclical / Execution-Driven Positioning
Auto Parts Operator
Competes within the Auto Parts value chain with $2.3M market capitalization and -2642.2% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ CRNT vs FRSX Key Questions & Quantitative Answers

As of Nov 16, 2026, Ceragon Networks Ltd (CRNT) is the stronger overall head-to-head candidate over Foresight Autonomous Holdings Ltd. (FRSX) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CRNT carries a Unified Composite Score of 26.6/100 (SELL) at $2.36 (13.7x Forward P/E, 3.5% operating margin), whereas FRSX carries 47.2/100 (HOLD) at $0.55 (N/M Forward P/E, -2642.2% operating margin). Composite vs. Pillar Nuance: While FRSX currently prints a higher short-term Unified Composite Score (47.2/100 HOLD vs. CRNT 26.6/100 SELL), CRNT captures the overall institutional head-to-head verdict (7–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (3.5% vs. -2642.2% operating margin) and revenue trajectory (+11.7% vs. -32.8% YoY). Technical & Structure Timing Caution: CRNT is currently in a Breakdown options structure phase (RSI 56.2); meanwhile FRSX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 20.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CRNT leads the Growth & Scale pillar: CRNT posts +11.7% YoY revenue growth and N/A YoY earnings growth on $357M TTM revenue (34.1% gross margin, 3.5% operating margin), compared with FRSX at -32.8% YoY revenue growth and +0.0% YoY earnings growth on $445,000 TTM revenue (65.4% gross margin, -2642.2% operating margin). On trailing 12-month operating scale, CRNT generates $357M in USD-normalized revenue versus $445,000 for FRSX. In operating R&D and SG&A reinvestment, CRNT deploys 30.6% of Rev ($109M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for FRSX.

CRNT screens cheaper on headline valuation multiples. CRNT trades at 13.7x Forward P/E, 15.7x Trailing P/E, 8.80x PEG, and 0.6x EV/Revenue (3.6% FCF margin), whereas FRSX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 5.2x EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CRNT (-0.5% ROE) versus FRSX (-205.9% ROE) capital efficiency.

In options market volatility and institutional positioning, CRNT carries 43.7% implied volatility (7th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (1.84β · 77% Vol realized risk). By comparison, FRSX carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.10β · 53% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.